Vistagen to attend upcoming Morgan Stanley and Baird Healthcare conferences

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Vistagen Therapeutics, Inc. (Nasdaq: VTGN) (Vistagen, the Company), a late-stage biopharmaceutical company focused on transforming the treatment landscape for people with anxiety, depression and other systemic disorders Central Nervous System (SNC), today announced that Chief Executive Officer Shawn Singh will attend upcoming investor conferences in New York. Management will be available for individual meetings during these conferences.

Morgan Stanley 20e Annual World Health Care Conference

Format: Fireside Chat

Date and time: Tuesday, September 13e at 9:10 a.m. Eastern Time

Location: New York, New York

The webcast will be accessible via the Events page in the Investors section of the Company’s website at

Baird Global Healthcare Conference 2022

Format: Fireside Chat

Date and time: Wednesday, September 14e 2:35 p.m. Eastern Time

Location: New York, New York

About Vistagen

Vistagen (Nasdaq: VTGN) is a late-stage, CNS-focused, clinical-stage biopharmaceutical company striving to transform the treatment landscape for people suffering from anxiety, depression and other CNS disorders. The Company is advancing therapies that may act more quickly and have fewer side effects and safety issues than those currently available. Vistagen clinical-stage candidates target multiple forms of anxiety and depression. PH94B and PH10 belong to a new class of drugs called pherins, which are odorless and tasteless experimental neuroactive steroids designed with a novel fast-acting mechanism that activates chemosensory neurons in the nasal passages and may impact olfactory neural circuits -tonsillars without systemic uptake or direct activity on CNS neurons in the brain. Vistagen is passionate about transforming mental health care and redefining what is possible in the treatment of anxiety and depression. Login to

Previous Rams vs Bills reactions: LA could have a slight Super Bowl hangover
Next A Chat With: Mt. Joy Returns to Philadelphia with Mann Center Headlining Concert